S-Space College of Medicine/School of Medicine (의과대학/대학원) Pathology (병리학전공) Journal Papers (저널논문_병리학전공)
Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy
- Kim, Kyubo; Chie, Eui Kyu; Kim, Chul Woo; Kim, Il Han; Park, Charn Il
- Issue Date
- Oxford University Press
- Jpn J Clin Oncol 2005;35(1):1-5.
- Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Combined Modality Therapy; Female; Humans; Immunophenotyping; *Killer Cells, Natural; Lymphoma, T-Cell/*drug therapy/mortality/*radiotherapy; Male; Middle Aged; Nose Neoplasms/*drug therapy/mortality/*radiotherapy; Radiotherapy Dosage; Survival Rate; Treatment Outcome
- OBJECTIVE: The purpose of this study was to evaluate the treatment outcome of angiocentric T-cell and natural killer (NK)/T-cell lymphoma, nasal type. METHODS: Between February 1989 and March 2001, 53 patients with newly diagnosed angiocentric T-cell and NK/T-cell lymphoma, nasal type involving the head and neck, were treated with radiation therapy (RT). There were 37 males and 16 females. The median age of the patients was 45 years (range 19-73). Twenty of them were treated with chemoradiotherapy (CRT), while 33 with treated with RT alone. The median follow-up period was 74 months (range 6-173). RESULTS: The 5-year overall survival rate of all patients was 69%. CRT appeared to be inferior to RT alone in terms of 5-year overall survival, though the difference was not statistically significant (59 versus 76%, P = 0.27). CONCLUSIONS: There was no difference in survival between RT and CRT in angiocentric T-cell and NK/T-cell lymphoma, nasal type.
- 0368-2811 (Print)
- Files in This Item: There are no files associated with this item.